← Back to OVID

Ovid Therapeutics Inc. - Common Stock financial statements

Annual and standalone quarterly facts filed by the company with the SEC. Monetary values are shown in USD millions; per-share values use USD.

Filed statements

USD; millions except EPSJun 2026Filed 13/08/2026Mar 2026Filed 13/08/2026Sep 2025Filed 12/11/2025Jun 2025Filed 13/08/2026Mar 2025Filed 13/08/2026Sep 2024Filed 12/11/2025Jun 2024Filed 12/11/2025Mar 2024Filed 12/11/2025
$0.7$0$0.1$6.3$0.1$0.2$0.2$0.1
−$15−$17−$12−$4.7−$10−$14$8.5−$12
−$0.20$0.12−$0.17
717171

Trend

Revenue

Source: SEC EDGAR Company Facts. Values are normalized from issuer-filed US GAAP or IFRS XBRL facts. Missing cells stay missing; cumulative interim cash flows are not converted into estimated quarters.